US 11964024
B7H4-targeted antibody-drug conjugates and methods of use thereof
granted A61KA61K2039/505A61K47/6803
Quick answer
US patent 11964024 (B7H4-targeted antibody-drug conjugates and methods of use thereof) held by Mersana Therapeutics, Inc. expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mersana Therapeutics, Inc.
- Grant date
- Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/505, A61K47/6803, A61K47/68031, A61K47/6807